Gilead Sciences, Inc.

Gilead Sciences, Inc.verified

GILD

Price:

$122.62

Market Cap:

$152.13B

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1992-01-22

Stock Exchange

NASDAQ

Ticker

GILD

The Enterprise Value as of December 2025 (TTM) for Gilead Sciences, Inc. (GILD) is 145.58B

According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 145.58B. This represents a change of 0.66% compared to the average of 144.63B of the last 4 quarters.

Gilead Sciences, Inc. (GILD) Historical Enterprise Value (quarterly & annually)

How has GILD Enterprise Value performed in the past?

The mean historical Enterprise Value of Gilead Sciences, Inc. over the last ten years is 116.77B. The current 145.58B Enterprise Value has changed 12.37% with respect to the historical average. Over the past ten years (40 quarters), GILD's Enterprise Value was at its highest in in the June 2025 quarter at 157.84B. The Enterprise Value was at its lowest in in the December 2018 quarter at 90.07B.

Quarterly (TTM)
Annual

Average

116.77B

Median

116.80B

Minimum

90.57B

Maximum

157.35B

Gilead Sciences, Inc. (GILD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gilead Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 14.11%

Maximum Annual Enterprise Value = 157.35B

Minimum Annual Increase = -27.55%

Minimum Annual Enterprise Value = 90.57B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024131.91B9.92%
2023120.00B-5.92%
2022127.56B13.33%
2021112.56B14.11%
202098.64B3.30%
201995.49B5.43%
201890.57B-24.26%
2017119.59B4.90%
2016114.00B-27.55%
2015157.35B7.89%

Gilead Sciences, Inc. (GILD) Average Enterprise Value

How has GILD Enterprise Value performed in the past?

The current Enterprise Value of Gilead Sciences, Inc. (GILD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

126.49B

5-year avg

118.13B

10-year avg

116.77B

Gilead Sciences, Inc. (GILD) Enterprise Value vs. Peers

How is GILD’s Enterprise Value compared to its peers?

Gilead Sciences, Inc.’s Enterprise Value is less than Pfizer Inc. (206.49B), less than Amgen Inc. (228.31B), greater than Sanofi (110.32B), greater than Bristol-Myers Squibb Company (141.07B), greater than GSK plc (87.84B), less than Merck & Co., Inc. (276.76B), less than Danaher Corporation (178.07B), less than Boston Scientific Corporation (156.36B), less than Novo Nordisk A/S (1.47T), less than Stryker Corporation (152.67B),

CompanyEnterprise ValueMarket cap
206.49B$146.12B
228.31B$183.17B
110.32B$119.14B
141.07B$105.76B
87.84B$98.75B
276.76B$253.56B
178.07B$162.74B
156.36B$144.86B
1.47T$213.32B
152.67B$139.33B

Build a custom stock screener for Gilead Sciences, Inc. (GILD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gilead Sciences, Inc. (GILD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Gilead Sciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Gilead Sciences, Inc. (GILD)?

What is the 3-year average Enterprise Value for Gilead Sciences, Inc. (GILD)?

What is the 5-year average Enterprise Value for Gilead Sciences, Inc. (GILD)?

How does the current Enterprise Value for Gilead Sciences, Inc. (GILD) compare to its historical average?